Glucose tolerance and insulin secretion were studied in non-diabetic littermates (n = 154) of BB diabetic rats, aged 4-6 months. Initial screening involved two intraperitoneal glucose tolerance tests (0.2 g/100 g body weight) performed one week apart. Nineteen rats (12%) were found to have impaired
Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance
โ Scribed by T. S. Berrish; C. S. Hetherington; K. G. M. M. Alberti; M. Walker
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 659 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
โฆ Synopsis
Recent evidence suggests that the postprandial hyperglycaemia in impaired glucose tolerance is primarily due to impaired suppression of basal hepatic glucose output. This in turn appears to be secondary to decreased first phase insulin secretion, although decreased hepatic insulin sensitivity, which is a feature of non-insulin-dependent diabetes mellitus, might also play a role. Eight mildly overweight subjects with impaired glucose tolerance and eight closely matched control subjects with normal glucose tolerance underwent an intravenous glucose tolerance test to assess first phase insulin secretion. Insulin sensitivity was examined by a 150-min hyperinsulinaemic-euglycaemic clamp. Somatostatin was infused from 150 rain to suppress endogenous insulin secretion, and glucagon and insulin were replaced by constant infusion. Glucose with added dideuterated glucose (labelled infusion technique) was infused to maintain euglycaemia. First phase insulin secretion (A 0-10min insulin area + A 0-10min glucose area) was significantly decreased in the subjects with impaired glucose tolerance (median [range]: 1.2 [0.2-19.4] vs 9.1 [2.6-14.5] mU. mmol-1; p < 0.01). During the clamp, circulating insulin (93 + 8
[mean + SEM] and 81 + 10 mU. 1-1) and glucagon (54 + 4 and 44 + 6 ng-1-1) levels were comparable. Total glucose disposal was decreased in subjects with impaired glucose tolerance (2.78 + 0.27 vs 4.47 _+ 0.53 mg. kg -a -min-1; p < 0.02), and was primarily due to decreased non-oxidative glucose disposal. However, hepatic glucose output rates were comparable during the clamp (0.38_+0.10 and 0.30 + 0.18 mg. kg -1 -min-1). Therefore, the main defects in subjects with impaired glucose tolerance are decreased first phase insulin secretion and peripheral non-oxidative glucose disposal, but hepatic glucose output shows normal responsiveness to insulin.
๐ SIMILAR VOLUMES
In a 5-12 year follow-up study of 288 subjects with impaired glucose tolerance after a 100-g glucose load, 48 worsened to overt Type 2 (non-insulin-dependent) diabetes with the elevation of fasting blood glucose. The initial level of blood glucose was a major predictor of subsequent worsening to dia
Insulin resistance was studied in seven non-obese male subjects with impaired glucose tolerance and four healthy, age and body-weight matched male control subjects by means of a continuous intravenous infusion of somatostatin, glucose and insulin over 150 min. Glucose tolerance was evaluated by mean